NCT07667114 Scapholunate Ligament Reconstruction Using Modified Flexor Carpi Radialis Tenodesis
| NCT ID | NCT07667114 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Waldfriede Hospital |
| Condition | Scapholunate Dissociation |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2026-07-01 |
| Primary Completion | 2027-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2026-07-01 with a primary completion date of 2027-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Retrospective study of patients who underwent a modified flexor carpi radialis (FCR) tenodesis for scapholunate ligament injury at Waldfriede Hospital during the period 2016-2026. Primary outcome: Functionality of the operated wrist measured using the validated DASH questionnaire.
Eligibility Criteria
Inclusion Criteria: * Age: ≥ 18 years * Capable of providing informed consent independently * Availability of written informed consent for the study Exclusion Criteria: * Active malignant disease * Pregnancy at the time of the examination * Presence of SLAC arthritis * Lack of capacity to provide independent consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07667114 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Scapholunate Dissociation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07667114 currently recruiting?
Yes, NCT07667114 is actively recruiting participants. Contact the research team at m.bock@waldfriede.de for enrollment information.
Where is the NCT07667114 trial being conducted?
This trial is being conducted at Berlin, Germany.
Who is sponsoring the NCT07667114 clinical trial?
NCT07667114 is sponsored by Waldfriede Hospital. The trial plans to enroll 100 participants.